Beta
ManageSearchChatDiscover
361190

OUTCOME OF SUBCYCLO DIODE LASER TRANSSCLERAL CYCLOPHOTOCOAGULATION FOR TREATMENT OF GLAUCOMA

Article

Last updated: 28 Dec 2024

OverviewSimilar Items

Subjects

-

Tags

-

Abstract

Purpose: The purpose of this study was to evaluate the efficacy and safety of micropulse transscleral cyclophotocoagulation (MP-TSCPC) for the treatment of glaucoma in patients whose
condition was not controlled with maximum tolerated antiglaucoma drugs or who were unable to
adhere to medication regimens. Methods: This prospective interventional study included 30
eyes from 22 patients treated at the Ophthalmology Department of Qena University Hospital
between January 2023 and January 2024. Patients underwent MP-TSCPC using the SubCyclo
Vitra 810 laser. Baseline and follow-up assessments at 1 week, 2 weeks, 1 month, 3 months, and
6 months included intraocular pressure (IOP) measurements, best-corrected visual acuity (BCVA),
and the number of antiglaucoma drugs used. Success was defined as achieving an IOP between
6 and 21 mmHg with or without antiglaucoma drugs, or a reduction in IOP of at least 20% from
baseline. Results: The mean age of participants was 55.93 years, with an equal distribution of
male and female patients. The majority (70%) had open-angle glaucoma. The mean number of
antiglaucoma drugs significantly decreased from 3.17 ± 0.93 at baseline to 1.20 ± 1.22 at 6
months (p < 0.0001). Baseline IOP was 26.7 ± 3.18 mmHg, which significantly reduced to 16.87
± 2.23 mmHg at 6 months (p < 0.0263). BCVA remained stable throughout the study period. The
success rate was 86.67%, with minimal complications observed. Conclusion: MP-TSCPC is an
effective and safe treatment modality for glaucoma, particularly for patients with difficulty adhering
to medication or those unwilling to undergo invasive surgery. The procedure significantly reduces
IOP and the need for antiglaucoma medications while preserving visual acuity with minimal
complications.

DOI

10.21608/ejco.2024.361190

Keywords

Glaucoma, Micropulse Transscleral Cyclophotocoagulation, MP-TSCPC, Intraocular Pressure, Antiglaucoma Medications, visual acuity, Minimally invasive surgery

Authors

First Name

Aldghaimy,

Last Name

A.

MiddleName

-

Affiliation

Ophthalmology dept., Faculty of Medicine, South Valley, Univ., Egypt,

Email

-

City

-

Orcid

-

Volume

7

Article Issue

1

Related Issue

48557

Issue Date

2024-06-01

Receive Date

2024-02-03

Publish Date

2024-06-01

Page Start

63

Page End

68

Print ISSN

2537-0502

Online ISSN

2537-0944

Article File

EJCO_Volume 7_Issue 1_Pages 63-68.pdf

PDF . 172.2kB

Link

https://ejco.journals.ekb.eg/article_361190.html

Detail API

https://ejco.journals.ekb.eg/service?article_code=361190

Order

8

Type

Original articles: include clinical trials, interventional research, Basic researches and clinically relevant laboratory investigations

Type Code

1,824

Publication Type

Journal

Publication Title

Egyptian Journal of Clinical Ophthalmology

Publication Link

https://ejco.journals.ekb.eg/

MainTitle

OUTCOME OF SUBCYCLO DIODE LASER TRANSSCLERAL CYCLOPHOTOCOAGULATION FOR TREATMENT OF GLAUCOMA

Details

Type

Article

Created At

28 Dec 2024